echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > With the quantity of procurement flowering everywhere, varieties expand into a trend

    With the quantity of procurement flowering everywhere, varieties expand into a trend

    • Last Update: 2020-05-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In mid-May, the State Drug Administration officially issued the Notice on the Quality and Efficacy Consistency evaluation of chemical injection strains, which clearly stated that in addition to sodium chloride injections, glucose injections, sodium glucose chloride injections, injecting water, some radioactive drugs and other varieties, the listed chemical injection sumosomes, and did not follow the principle of approval of the original drug quality and efficacy of the varieties to carry out consistent evaluationband procurement blossomed everywhere, varieties expanded into a trend
    and with the injection consistency evaluation requirements to land, domestic injection band procurement also began to advance rapidlyOn May 25, Shanxi injection collection selection results announced, 17 enterprises 29 product regulations to win the bid, it is known that the decline or more than 50%, Qilu Pharmaceuticals, Luoxin, Ha Pharmaceutical and other well-known enterprises are listed in a number of productsin addition, it is worth noting that recently, the Qinghai Provincial Medical Security Bureau issued "on the submission of the 2020 provincial organizations to centralize the purchase of drugs-related data notice", involving 64 varieties (146 product regulations), including 41 injectable varietiesthus shows that the range of local collection catalogue is expanding, and the range of varieties and dosage forms is also increasingIn fact, from 2019 onwards, centralized procurement of drugs has entered a rapid development phaseIn particular, in 2019, the state has issued two successive heavy documents to deepen drug procurementThey are the Notice on Further Promoting the Experience of Deepening the Reform of the Medical and Health System in Fujian Province and Sanming City and the Notice on The Notice on The Measures of Further Deepening the Reform of the Medical and Health System with the Central Procurement and Use of Drugs as the breakthroughIt further clarifies the specific tasks and organizations of the centralized procurement of medicines in various regions and related departmentsat present, with policy support to explore more individual or provincial alliance band procurement, as well as the expansion of varieties, scope of action is also increasingFor example, on April 15th, Hunan's special procurement of antibiotics was announced, with a total of 154 bids for 52 varietiesIn addition to some small and medium-sized enterprises, there are national pharmaceutical group, Shanghai pharmaceutical, North China pharmaceutical and other leading enterprises, multinational pharmaceutical enterprises only Bayer won the bidApril 20, Shanxi Pharmaceutical Sei-Focused Bidding Procurement Network announced the launch of the province's drug group alliance centralized quantity procurement pilotThis Shanxi collection is mainly aimed at the clinical use of mature, large procurement amount, relatively full competition for 21 common injectable varieties, a total of 35 specifications of drugs, covering antimicrobial drugs, anti-cancer drugs and other fields in addition to the , Jiangxi Province pharmaceutical procurement service platform in recent days also released the "Jiangxi Province drug centralized band procurement evaluation rules for public consultation" said that the pharmaceutical procurement service platform issued in Jiangxi Province, the comprehensive evaluation rules for centralized drug collection procurement (draft for comments), open to the community to seek advice, which marks that the non-consistent evaluation of the centralized band procurement of drugs will enter the practical stage overall, as the focus on drug procurement deepens, more varieties and a wider range of drugs will be included in the procurement in the future, or will have more impact on pharmaceutical companies Among them, those who do not have strong research and development capabilities, no unique varieties of enterprises may be accelerated phase-out.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.